{"podcast":{"title":"Cell & Gene: The Podcast","slug":"cell-gene-the-podcast-4048431","podcast_index_feed_id":4048431,"rss_url":"https://rss.buzzsprout.com/1810482.rss","website_url":"https://www.buzzsprout.com/1810482","image_url":"https://storage.buzzsprout.com/f3p8rfd9kizh4zywm5msg5goq7nu?.jpg","author":"Erin Harris","episode_count":140,"summary":"Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.","last_synced_at":"2026-06-18T18:19:19.741610+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431"},"episode":{"title":"Advancing Off-the-Shelf CRISPR CAR-T Therapies into the Community Setting with Caribou Biosciences' Rachel Haurwitz","slug":"advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz","published_at":"2026-01-15T11:00:00+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz","show_page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431","url":"https://www.buzzsprout.com/1810482/episodes/18499803-advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz.mp3","audio_url":"https://www.buzzsprout.com/1810482/episodes/18499803-advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz.mp3","summary":"We love to hear from our listeners. Send us a message. Welcome to episode 120 of Cell & Gene: The Podcast. Host Erin Harris is joined by Rachel Haurwitz, CEO of Caribou Biosciences, to discuss the company’s progress in developing CRISPR-edited, off-the-shelf CAR-T therapies for hematologic malignancies. Their conversation centers on Vispacell, Caribou’s allogeneic CD19 CAR-T for second-line large B-cell lymphoma. Haurwitz explains how Caribou has systematically optimized its allogeneic pl...","meta_description":"We love to hear from our listeners. Send us a message. Welcome to episode 120 of Cell & Gene: The Podcast. Host Erin Harris is joined by Rachel Haurwi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1172,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/advancing-off-the-shelf-crispr-car-t-therapies-into-the-community-setting-with-caribou-biosciences-rachel-haurwitz.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}